Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

BACKGROUND: The risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) is thought to be increased following anti-tumour necrosis factor (anti-TNF) therapy, with a proposed differential risk between the anti-TNF drugs etanercept (ETA), infliximab (INF) and adalimumab (ADA). OBJECTIVE: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, W G, Hyrich, K L, Watson, K D, Lunt, M, Galloway, J, Ustianowski, A, Symmons, D P M
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927681/
https://www.ncbi.nlm.nih.gov/pubmed/19854715
http://dx.doi.org/10.1136/ard.2009.118935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927681/
https://www.ncbi.nlm.nih.gov/pubmed/19854715
http://dx.doi.org/10.1136/ard.2009.118935

Ejemplares similares